Á. Hoyo-Muñoz

Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents

V. Escudero-Vilaplana, Miguel Martín, M. Sanjurjo, 2022, Journal of Cancer Research and Clinical Oncology.

Thalidomide as treatment of refractory thoracic Rosai‐Dorfman disease

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2021, Journal of clinical pharmacy and therapeutics.

Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice

V. Escudero-Vilaplana, Miguel Martín, M. Sanjurjo, 2021, Supportive Care in Cancer.

Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2020, Expert opinion on drug safety.